Other
Remifentanil
0
Pipeline Programs↗
1
Active Trials↗
0
Companies Involved↗
Remifentanil is an early-stage landscape with 0 programs across 0 companies.
Intelligence
Pipeline Metrics
Competitive Density
Pipeline Velocity
Mech. Concentration
Completion Rate
Attrition Rate
Pipeline
Programs by Phase
No pipeline programs currently tracked for this disease.
Analysis
Trial Status
67
clinical trials
Completed54 · 81%
Unknown status9 · 13%
Terminated2 · 3%
Recruiting1 · 1%
Withdrawn1 · 1%
Clinical Trials
Trial Activity
67 trials
Sugammadex on Remifentanil Ce for Preventing Emergence Cough in Female
Completed·—·N/A·NCT04407078·40 enrolled
Efficacy of Two Bolus Doses of Remifentanil on the Incidence of Coughing During Emergence of Anesthesia
Completed·—·N/A·NCT01489072·180 enrolled
Remifentanil and Stress Hormones Response
Completed·—·N/A·NCT03378674·50 enrolled
Intubating Conditions During Propofol-remifentanil Anesthesia With Topical Lidocaine
Completed·—·N/A·NCT01489683·50 enrolled
Efficacy of Remifentanil Compared to Lidocaine on the Incidence of Coughing During Emergence of Anesthesia
Completed·—·N/A·NCT01026129·93 enrolled
EC95 of Remifentanil for Preventing Cough
Completed·—·N/A·NCT02973724·40 enrolled
Page 1 of 5
Data sources: ClinicalTrials.gov (NIH) · OpenFDA (FDA) · ChEMBL (EMBL-EBI) · Open Targets (EBI/Sanger) · MedlinePlus (NIH) · PubMed (NIH) · SEC EDGAR (SEC)